The Centers for Medicare & Medicaid Services today issued guidance on designing state approaches to covering treatment services for Medicaid-eligible infants with neonatal abstinence syndrome. “Through discussions with states, we have recognized their growing challenge in providing treatment services to the expanding number of infants with NAS,” said Tim Hill, acting director of the Center for Medicaid and CHIP Services. “We have also recognized that states may not be fully aware of available options under Medicaid that can play a critical role in the care of these infants, as well as the limitations on Medicaid coverage.” In addition, CMS issued a letter to state Medicaid directors on funding authorities that may support health information technology efforts to address the opioid crisis.

Related News Articles

Headline
The Government Accountability Office yesterday named two new members to the Medicaid and CHIP Payment and Access Commission.
Headline
Despite some progress in transparency related to the process for Section 1115 Medicaid waivers, the Centers for Medicare…
Perspective
When the many vulnerable members of society need care, they often turn to their local hospital or health system.
Headline
The House Ways and Means Committee today held a hearing examining the impact of racial disparities and social determinants of health on maternal mortality.
Headline
The Centers for Medicare…
Headline
Three hundred two members of the House of Representatives yesterday urged House leadership to delay for at least two years the Medicaid disproportionate share…